Predictions
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€362.80
29.10.22
29.10.22
€400.00
29.10.23
29.10.23
6.95%
05.05.23
05.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€2.68
29.10.22
29.10.22
-
29.10.23
29.10.23
40.63%
30.10.23
30.10.23
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€85.88
28.10.22
28.10.22
-
28.10.23
28.10.23
16.27%
18.05.23
18.05.23
Risky Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.68
28.10.22
28.10.22
-
28.10.23
28.10.23
-7.17%
18.05.23
18.05.23
Risky Investment
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€7.95
28.10.22
28.10.22
-
28.10.23
28.10.23
-16.20%
29.10.22
29.10.22
Could be very worthwhile Investment >20% year
Inventiva SA
Start price
Target price
Perf. (%)
€6.02
27.10.22
27.10.22
-
27.10.23
27.10.23
-42.03%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€17.96
26.10.22
26.10.22
€28.00
31.12.24
31.12.24
15.29%
08.06.24
08.06.24
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.67
26.10.22
26.10.22
€35.00
31.12.24
31.12.24
-41.33%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€9.52
26.10.22
26.10.22
-
26.10.23
26.10.23
-30.01%
30.10.22
30.10.22
Could be very worthwhile Investment >20% year
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.78
25.10.22
25.10.22
€5.00
31.12.24
31.12.24
-23.55%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Immunic Inc.
Start price
Target price
Perf. (%)
€1.72
24.10.22
24.10.22
-
24.10.23
24.10.23
-21.87%
18.11.22
18.11.22
Risky Investment
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.80
24.10.22
24.10.22
€4.50
24.10.23
24.10.23
-3.11%
25.10.23
25.10.23
Could be worthwhile Investment >10% per year
XOMA Corp.
Start price
Target price
Perf. (%)
€16.40
24.10.22
24.10.22
€20.00
24.10.23
24.10.23
-6.10%
25.10.23
25.10.23
Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€2.12
24.10.22
24.10.22
€3.00
24.10.23
24.10.23
-73.07%
25.10.23
25.10.23
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.80
24.10.22
24.10.22
€7.00
24.10.23
24.10.23
18.42%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Viatris Inc.
Start price
Target price
Perf. (%)
€9.76
18.10.22
18.10.22
-
18.11.26
18.11.26
13.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Pfizer Inc.
Start price
Target price
Perf. (%)
€44.90
18.10.22
18.10.22
-
18.11.26
18.11.26
-44.54%
11.03.24
11.03.24
Probably not worthwhile Investment
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
18.10.22
18.10.22
-
18.10.23
18.10.23
0.78%
29.10.22
29.10.22
Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques